Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00474617
Status:
COMPLETED
Last Update Posted:
2019-04-02
First Post:
2007-05-15
Brief Title:
Comparison of the Efficacy Safety and Pharmacokinetics of Sugammadex MK-8616 Org 25969 in Elderly Participants With Adult Participants MK-8616-029
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Multicenter Parallel Group Comparative Phase IIIa Trial to Compare the Efficacy Safety and Pharmacokinetics of Org 25969 in Elderly Subjects With Adult Subjects
Status:
COMPLETED
Status Verified Date:
2019-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to compare the effectiveness safety and pharmacokinetics of sugammadex in participants 65 and over with participants under 65 There is no hypothesis defined for the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 194305 | OTHER | None | None |
| P05950 | OTHER | None | None |
| MK-8616-029 | OTHER | Merck Protocol Number | None |